Valeant Short Sellers Net 343% Profit As Eyes Turn To John Paulson – ValueWalk Premium

Valeant Short Sellers Net 343% Profit As Eyes Turn To John Paulson

As Bill Ackman and Pershing Square Capital Management are licking their recent wounds due to well-publicized trades in Herbalife  Ltd. (NYSE:HLF) and Valeant Pharmaceuticals (NYSE:VRX), there are winners as well as losers. As short sellers count their profits, and gradually reduce their exposure, they eye hedge fund manager John Paulson, whose Paulson & Company is still long the stock, for a squeeze opportunity.

Ackman's . . .

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk

The top investors are reading ValuewalkPremium.

Click here to learn why

0